The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention.

The discovery of highly divergent strains of human immunodeficiency virus (HIV) not reliably detected by a number of commonly used diagnostic tests has underscored the need for effective surveillance to track HIV variants and to direct research and prevention activities. Pathogens such as HIV that mutate extensively present significant challenges to effective monitoring of pathogens and to disease control. To date, relatively few systematic large-scale attempts have been made to characterize and sequence HIV isolates. For most of the world, including the United States, information on the distribution of HIV strains among different population groups is limited. We describe herein the implications resulting from the rapid evolution of HIV and the need for systematic surveillance integrated with laboratory science and applied research. General surveillance guidelines are provided to assist in identifying population groups for screening, in applying descriptive epidemiology and systematic sampling, and in developing and evaluating efficient laboratory testing algorithms. Timely reporting and dissemination of data is also an important element of surveillance efforts. Ultimately, the success of global surveillance network depends on collaboration and on coordination of clinical, laboratory, and epidemiologic efforts.

[1]  J. Chermann,et al.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). , 1983, Science.

[2]  P. Sharp,et al.  Recombination in HIV-1 , 1995, Nature.

[3]  A. Perelson,et al.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.

[4]  J. Mullins,et al.  Identification of an env G subtype and heterogeneity of HIV‐1 strains in the Russian Federation and Belarus , 1994, AIDS.

[5]  J. Mascola,et al.  Dual infection with human immunodeficiency virus type 1 of distinct envelope subtypes in humans. , 1995, The Journal of infectious diseases.

[6]  P. Sharp,et al.  Rates and dates of divergence between AIDS virus nucleotide sequences. , 1988, Molecular biology and evolution.

[7]  C. Cheng‐Mayer,et al.  Biologic features of HIV-1 that correlate with virulence in the host. , 1988, Science.

[8]  S. J. Clark,et al.  High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. , 1993, Science.

[9]  HIV-1 patients may harbor viruses of different phylogenetic subtypes: implications for the evolution of the HIV/AIDS pandemic. , 1995, Emerging infectious diseases.

[10]  P. Lurie,et al.  Ethical, behavioral, and social aspects of HIV vaccine trials in developing countries. , 1994, JAMA.

[11]  H. Whittle,et al.  HIV-2-induced immunosuppression among asymptomatic West African prostitutes: evidence that HIV-2 is pathogenic, but less so than HIV-1. , 1991, AIDS.

[12]  M. Cloyd,et al.  Spectrum of biological properties of human immunodeficiency virus (HIV-1) isolates. , 1990, Virology.

[13]  R. Doolittle The simian—human connection , 1989, Nature.

[14]  P. Sharp,et al.  HIV-1 sequence subtype D in the United States. , 1994, AIDS research and human retroviruses.

[15]  D. Ho,et al.  Genetic analysis of human immunodeficiency virus type 1 strains from patients in Cyprus: identification of a new subtype designated subtype I , 1995, Journal of virology.

[16]  B. Korber,et al.  Signature pattern analysis: a method for assessing viral sequence relatedness. , 1992, AIDS research and human retroviruses.

[17]  B. Korber,et al.  Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences , 1994, Journal of virology.

[18]  Y. Takebe,et al.  The molecular epidemiology of HIV in Asia. , 1994, AIDS.

[19]  P. Kaleebu,et al.  Molecular epidemiology of HIV‐1 in the former Soviet Union: analysis of env V3 sequences and their correlation with epidemiologic data , 1994, AIDS.

[20]  R. Desrosiers,et al.  Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses , 1987, Nature.

[21]  P. Kaleebu,et al.  Serotyping HIV type 1 by antibody binding to the V3 loop: relationship to viral genotype. WHO Network for HIV Isolation and Characterization. , 1994, AIDS research and human retroviruses.

[22]  J. Fitzgibbon,et al.  Transmission from one child to another of human immunodeficiency virus type 1 with a zidovudine-resistance mutation. , 1993, The New England journal of medicine.

[23]  S. Osmanov HIV Type 1 Variation in World Health Organization-Sponsored Vaccine Evaluation Sites: Genetic Screening, Sequence Analysis, and Preliminary Biological Characterization of Selected Viral Strains , 1994 .

[24]  C. Luo,et al.  HIV-1 subtype C in China , 1995, The Lancet.

[25]  N. Torre,et al.  Wide distribution of two subtypes of HIV-1 in Thailand. , 1992, AIDS research and human retroviruses.

[26]  B. Korber,et al.  Standard conditions of virus isolation reveal biological variability of HIV type 1 in different regions of the world. WHO Network for HIV Isolation and Characterization. , 1994, AIDS research and human retroviruses.

[27]  H. von Briesen,et al.  HIV-1 and HIV-2 infections in a high-risk population in Bombay, India: evidence for the spread of HIV-2 and presence of a divergent HIV-1 subtype. , 1992, Journal of acquired immune deficiency syndromes.

[28]  P. Thongcharoen,et al.  HIV-1 Variants in South and South-East Asia , 1995, International journal of STD & AIDS.

[29]  R. Redfield,et al.  Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS. , 1986, Science.

[30]  S. Knapp,et al.  A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon , 1994, Journal of virology.

[31]  C. Loveday,et al.  HIV-1 RNA serum-load and resistant viral genotypes during early zidovudine therapy , 1995, The Lancet.

[32]  Katherine Spindler,et al.  Rapid evolution of RNA genomes. , 1982, Science.

[33]  S. Dewhurst,et al.  Differences in cytopathogenicity and host cell range among infectious molecular clones of human immunodeficiency virus type 1 simultaneously isolated from an individual , 1988, Journal of virology.

[34]  T. O'Brien,et al.  HIV-2 infection in an American. , 1991, AIDS.

[35]  Joshua Lederberg,et al.  Emerging Infections: Microbial Threats to Health in the United States , 1992 .

[36]  F. Dias,et al.  A prospective study of vertical transmission of HIV-2 in Bissau, Guinea-Bissau. , 1993, AIDS.

[37]  J. Kaldor,et al.  Patient-to-patient transmission of HIV in private surgical consulting rooms , 1993, The Lancet.

[38]  M. Kalish,et al.  Antigenic variation and serotyping of HIV type 1 from four World Health Organization-sponsored HIV vaccine sites. WHO Network for HIV Isolation and Characterization. , 1994, AIDS research and human retroviruses.

[39]  M. Peeters,et al.  Isolation and partial characterization of an HIV-related virus occurring naturally in chimpanzees in Gabon. , 1989, AIDS.

[40]  C. Kuiken,et al.  Increasing antigenic and genetic diversity of the V3 variable domain of the human immunodeficiency virus envelope protein in the course of the AIDS epidemic. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[41]  S D Kemp,et al.  Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). , 1989, Science.

[42]  Characterization,et al.  Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization. , 1994, AIDS research and human retroviruses.

[43]  D. Ho,et al.  Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals , 1993, Journal of virology.

[44]  J. Kaldor,et al.  HIV infection in recipients of blood products from donors with known duration of infection , 1994, The Lancet.

[45]  L. Kestens,et al.  Immunological comparison of HIV‐1-, HIV‐2− and dually‐reactive women delivering in Abidjan, Côte d'lvoire , 1992, AIDS.

[46]  J. Albert,et al.  Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates , 1988, Journal of virology.

[47]  D. Burke,et al.  Phylogenetic analysis of gag genes from 70 international HIV‐1 isolates provides evidence for multiple genotypes , 1993, AIDS.

[48]  B. Korber,et al.  HIV-1 sequence variation between isolates from mother-infant transmission pairs. , 1992, AIDS research and human retroviruses.

[49]  J. Levy,et al.  Characterization of human immunodeficiency virus type 1 isolates from children in Romania: identification of a new envelope subtype. , 1994, The Journal of infectious diseases.

[50]  N. Haigwood,et al.  V3 variability can influence the ability of an antibody to neutralize or enhance infection by diverse strains of human immunodeficiency virus type 1. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[51]  G. Shaw,et al.  Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo , 1992, Journal of virology.

[52]  F. Brun-Vézinet,et al.  Isolation of a new human retrovirus from West African patients with AIDS. , 1986, Science.

[53]  G. Schochetman,et al.  AIDS testing : a comprehensive guide to technical, medical, social, legal, and management issues , 1994 .

[54]  F. McCutchan,et al.  Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1. , 1993, The New England journal of medicine.

[55]  J. Mascola,et al.  Detection of diverse HIV-1 genetic subtypes in the USA , 1995, The Lancet.

[56]  D. Raoult,et al.  Human granulocytic ehrlichiosis in Europe , 1995, The Lancet.

[57]  H. Gayle,et al.  Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic. , 1993, JAMA.

[58]  E. Holmes,et al.  The molecular epidemiology of human immunodeficiency virus type 1 in Edinburgh. , 1995, The Journal of infectious diseases.

[59]  N. Saitou,et al.  The neighbor-joining method: a new method for reconstructing phylogenetic trees. , 1987, Molecular biology and evolution.

[60]  H. Whittle,et al.  HIV‐2-infected patients survive longer than HIV‐1 -infected patients , 1994, AIDS.

[61]  H. Jaffe,et al.  Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections , 1994, The Lancet.

[62]  D. Ho,et al.  Quantitation of zidovudine-resistant human immunodeficiency virus type 1 in the blood of treated and untreated patients. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[63]  C. Luo,et al.  Early HIV type 1 strains in Thailand were not responsible for the current epidemic. , 1994, AIDS research and human retroviruses.

[64]  H. Gayle,et al.  Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand , 1993, The Lancet.

[65]  I. Thior,et al.  Slower heterosexual spread of HIV-2 than HIV-1 , 1994, The Lancet.

[66]  P. Piot,et al.  Genetic comparison of HIV-1 isolates from Africa, Europe, and North America. , 1992, AIDS research and human retroviruses.

[67]  J. Huelsenbeck,et al.  Application and accuracy of molecular phylogenies. , 1994, Science.

[68]  C Y Ou,et al.  DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells. , 1988, Science.

[69]  I. Thior,et al.  Reduced rate of disease development after HIV-2 infection as compared to HIV-1. , 1994, Science.

[70]  F. Brun-Vézinet,et al.  HIV-1/HIV-2 seronegativity in HIV-1 subtype 0 infected patients , 1994, The Lancet.

[71]  H. Gayle,et al.  Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast. , 1994, JAMA.

[72]  H. Vinters,et al.  Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. , 1987, Science.

[73]  C. Williamson,et al.  HIV-1 subtypes in different risk groups in South Africa , 1995, The Lancet.

[74]  W. Li,et al.  A statistical test of phylogenies estimated from sequence data. , 1989, Molecular biology and evolution.

[75]  R. Gallo,et al.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. , 1984, Science.

[76]  D. Richman,et al.  HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. , 1989, Science.

[77]  T. Quinn Population migration and the spread of types 1 and 2 human immunodeficiency viruses. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[78]  J. Kaldor,et al.  Long-term symptomless HIV-1 infection in recipients of blood products from a single donor , 1992, The Lancet.

[79]  A. Fauci,et al.  The immunopathogenesis of human immunodeficiency virus infection. , 1993, The New England journal of medicine.

[80]  F. Gao,et al.  Origins and diversity of human immunodeficiency viruses , 1994 .

[81]  E. G. Shpaer,et al.  Identification of human immunodeficiency virus type 1 envelope genes recombinant between subtypes B and F in two epidemiologically linked individuals from Brazil , 1994, Journal of virology.

[82]  T. Dondero,et al.  HIV-1 variants: yet another challenge to public health , 1994, The Lancet.

[83]  L. Zekeng,et al.  Prevalence of HIV-1 subtype O infection in Cameroon: preliminary results. , 1994, AIDS.

[84]  J. Felsenstein Phylogenies from molecular sequences: inference and reliability. , 1988, Annual review of genetics.

[85]  L. Heyndrickx,et al.  Isolation and partial characterization of an unusual human immunodeficiency retrovirus from two persons of west-central African origin , 1990, Journal of virology.

[86]  B. Korber,et al.  Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. , 1992, Science.

[87]  P. Phanuphak,et al.  HIV-1 subtypes and male-to-female transmission in Thailand , 1995, The Lancet.

[88]  J. Goudsmit,et al.  Simultaneous introduction of distinct HIV‐1 subtypes into different risk groups in Russia, Byelorussia and Lithuania , 1995, AIDS.

[89]  Others,et al.  A comparison of HIV‐1 and HIV‐2 infections in hospitalized patients in Abidjan, Côte d'lvoire , 1990, AIDS.

[90]  W. Heneine,et al.  Detection of reverse transcriptase by a highly sensitive assay in sera from persons infected with human immunodeficiency virus type 1. , 1995, The Journal of infectious diseases.

[91]  F. Muggia,et al.  Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men--New York City and California. , 1981, MMWR. Morbidity and mortality weekly report.

[92]  E. G. Shpaer,et al.  Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. , 1993, Science.

[93]  M. Kalish,et al.  Lack of HIV Transmission in the Practice of a Dentist with AIDS , 1994, Annals of Internal Medicine.

[94]  D. Richman,et al.  The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. , 1994, The Journal of infectious diseases.

[95]  J. Mullins,et al.  Molecular Epidemiology of HIV Transmission in a Dental Practice , 1992, Science.

[96]  Martin A. Nowak,et al.  Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.

[97]  J. Mascola,et al.  Multiple introductions of HIV-1 subtype E into the western hemisphere , 1995, The Lancet.

[98]  R. F. Smith,et al.  Human retroviruses and aids, 1992 , 1992 .

[99]  J. Mullins,et al.  Genetic analysis of HIV-1 isolates from Brazil reveals presence of two distinct genetic subtypes. , 1994, AIDS research and human retroviruses.

[100]  P. Piot,et al.  The prevalence of infection with human immunodeficiency virus over a 10-year period in rural Zaire. , 1988, The New England journal of medicine.

[101]  P. Piot,et al.  Correlation between genetic and biological properties of biologically cloned HIV type 1 viruses representing subtypes A, B, and D. , 1995, AIDS research and human retroviruses.

[102]  J. Sarthou,et al.  HIV-2 and HIV-1 AIDS cases in Senegal: clinical patterns and immunological perturbations. , 1991, Journal of acquired immune deficiency syndromes.

[103]  H. Schuitemaker,et al.  Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population , 1992, Journal of virology.

[104]  A. Featherstone,et al.  Reactions of Ugandan antisera with peptides encoded by V3 loop epitopes of human immunodeficiency virus type 1. , 1994, AIDS research and human retroviruses.

[105]  T. Ryder,et al.  Rapid and quantitative detection of enzymatically amplified HIV-1 DNA using chemiluminescent oligonucleotide probes. , 1990, AIDS research and human retroviruses.

[106]  F. Brun-Vézinet,et al.  Seroepidemiological survey of HIV-1 and HIV-2 antibodies in Gabon. , 1988, AIDS.

[107]  Wei-Shau Hu,et al.  Retroviral recombination and reverse transcription. , 1990, Science.

[108]  H Hui,et al.  Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology , 1994, Journal of virology.